DAWN logo

Day One Biopharmaceuticals, Inc. (DAWN)

Profile

Full Name

Day One Biopharmaceuticals, Inc.

Ticker

NASDAQ: DAWN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 27, 2021

Indexes

Not included

Website

https://dayonebio.com

Employees

181

Key Details

Price

$7.55(+1.89%)

Market cap

$773.36M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$131.16M(+100.00% YoY)

Annual EPS

-$1.02(+56.96% YoY)

PE ratio

-

Next earnings date

Oct 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.55
    DAWN price is $7.55

    30-Day Relative Volume

    0.51
    DAWN 30-day relative volume is 0.51

    Price Performance

    Price Most recent change

    +1.89%
    DAWN price was up +1.89% on Sep 5, 2025

    Price YTD change

    -40.41%
    DAWN price is down -40.41% since January 1st

    Price 1-year change

    -47.93%
    DAWN price is down -47.93% year-on-year

    Price 3-year change

    -68.28%
    DAWN price is down -68.28% over the past 3 years

    Price Range

    Price All-time high

    $28.70
    DAWN price is currently -73.69% below its historical high of $28.70

    Price 3-year low

    $5.63
    DAWN price is currently +33.98% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $773.36M
    DAWN market capitalization is $773.36 million

    Market cap 3-year change

    -55.77%
    DAWN market capitalization is down -55.77% over the past 3 years

    Market cap All-time high

    $1.95B
    DAWN market capitalization is currently -60.38% below its historical high of $1.95 billion

    Market cap sector rank

    69.52%
    DAWN market capitalization is higher than 69.52% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.19%
    DAWN shares outstanding is up +4.19% year-on-year

    Shares Outstanding 3-Year Change

    +39.44%
    DAWN shares outstanding is up +39.44% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.02
    DAWN beta is 1.02

    200-day SMA

    $9.01
    DAWN price is currently -16.19% below its 200-day simple moving average

    50-day SMA

    $6.80
    DAWN price is currently +11.07% above its 50-day simple moving average

    RSI

    62.73
    DAWN 14-day relative strength index is 62.73

    Volume

    0.51
    DAWN 30-day relative volume is 0.51

    ATR

    $0.32
    DAWN average true range is $0.32

    10-day Historical Volatility

    45.70%
    DAWN 10-day historical volatility is 45.70%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $131.16M
    DAWN annual revenue is $131.16 million

    Revenue Analysts estimate

    $144.96M
    DAWN annual revenue is currently -9.52% lower than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    DAWN annual revenue is up +100% year-on-year

    Revenue Sector rank

    70.47%
    DAWN annual revenue is higher than 70.47% of companies in Healthcare sector

    EPS

    EPS

    -$1.02
    DAWN annual earnings per share is -$1.02

    EPS Analysts estimate

    -$1.17
    DAWN annual earnings per share is currently -12.87% lower than the consensus analysts' forecast

    EPS 1-year change

    +56.96%
    DAWN annual earnings per share is up +56.96% year-on-year

    EPS Sector rank

    51.76%
    DAWN annual earnings per share is higher than 51.76% of companies in Healthcare sector

    Profit

    Gross profit

    $125.88M
    DAWN annual gross profit is $125.88 million

    Gross margin

    95.98%
    DAWN annual gross profit margin is 95.98%

    Operating profit

    -$217.27M
    DAWN annual operating income is -$217.27 million

    Operating margin

    -165.65%
    DAWN annual operating profit margin is -165.65%

    Net income

    -$95.50M
    DAWN annual net profit is -$95.50 million

    Net margin

    -72.81%
    DAWN annual net profit margin is -72.81%

    Expenses

    Total expenses

    $348.43M
    DAWN annual total expenses is $348.43 million

    Operating expenses

    $343.15M
    DAWN annual total operating expenses is $343.15 million

    Cost of goods sold

    $5.28M
    DAWN annual cost of goods sold is $5.28 million

    Selling, general & administrative expenses

    $115.45M
    DAWN annual SGA is $115.45 million

    Depreciation and amortization

    $2.03M
    DAWN annual depreciation & amortization is $2.03 million

    Interest expense

    $0.00
    DAWN annual interest expense is $0.00

    Income tax

    $7.14M
    DAWN annual income tax is $7.14 million

    EBIT & EBITDA

    EBIT

    -$217.27M
    DAWN annual earnings before interest & taxes is -$217.27 million

    EBITDA

    -$215.24M
    DAWN annual EBITDA is -$215.24 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $582.79M
    DAWN annual total assets is $582.79 million

    Non current assets

    $20.46M
    DAWN annual long term assets is $20.46 million

    Current assets

    $562.33M
    DAWN annual total current assets is $562.33 million

    Cash and cash equivalents

    $124.97M
    DAWN annual cash & cash equivalents is $124.97 million

    Accounts receivable

    $13.88M
    DAWN annual accounts receivable is $13.88 million

    Inventory

    $3.32M
    DAWN annual inventory is $3.32 million

    Liabilities

    Total liabilities

    $80.04M
    DAWN annual total liabilities is $80.04 million

    Long term liabilities

    $6.59M
    DAWN annual total long term liabilities is $6.59 million

    Current liabilities

    $73.45M
    DAWN annual total current liabilities is $73.45 million

    Accounts payable

    $3.26M
    DAWN annual accounts payable is $3.26 million

    Debt

    Total debt

    $2.60M
    DAWN annual total debt is $2.60 million

    Total debt 1-year change

    +537.75%
    DAWN annual total debt is up +537.75% year-on-year

    Long term debt

    $2.59M
    DAWN annual long term debt is $2.59 million

    Short term debt

    $10.00K
    DAWN annual short term debt is $10.00 thousand

    Equity & Capital

    Shareholders equity

    $502.75M
    DAWN annual stockholders equity is $502.75 million

    Book value

    $502.75M
    DAWN annual book value is $502.75 million

    Retained earnings

    -$554.08M
    DAWN annual retained earnings is -$554.08 million

    Working capital

    $488.88M
    DAWN annual working capital is $488.88 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$78.11M
    DAWN annual cash flow from operations is -$78.11 million

    Cash from operations 1-year change

    +46.81%
    DAWN annual cash flow from operations is up +46.81% year-on-year

    Cash from investing

    -$230.99M
    DAWN annual cash flow from investing activities is -$230.99 million

    Cash from investing 1-year change

    -279.93%
    DAWN annual cash flow from investing activities is down -279.93% year-on-year

    Cash from financing

    $203.29M
    DAWN annual cash flow from financing activities is $203.29 million

    Cash from financing 1-year change

    +23.96%
    DAWN annual cash flow from financing activities is up +23.96% year-on-year

    CAPEX

    CAPEX

    $19.27M
    DAWN annual capital expenditures is $19.27 million

    CAPEX 1-year change

    +8502.23%
    DAWN annual capital expenditures is up +8502.23% year-on-year

    Free Cash Flow

    Free cash flow

    -$152.38M
    DAWN annual free cash flow is -$152.38 million

    Free cash flow 1-year change

    -1.54%
    DAWN annual free cash flow is down -1.54% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    95.98%
    DAWN annual gross profit margin is 95.98%

    Operating margin

    -165.65%
    DAWN annual operating profit margin is -165.65%

    Net margin

    -72.81%
    DAWN annual net profit margin is -72.81%

    ROA & ROE

    ROA

    -19.92%
    DAWN annual return on assets is -19.92%

    ROE

    -22.49%
    DAWN annual return on equity is -22.49%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DAWN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DAWN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.68
    DAWN price to book ratio is 1.68

    PB ratio Sector rank

    47.98%
    DAWN price to book ratio is higher than 47.98% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.12
    DAWN price to sales ratio is 4.12

    PS ratio Sector rank

    53.1%
    DAWN price to sales ratio is higher than 53.1% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $323.26M
    DAWN enterprise value is $323.26 million

    Enterprise value Sector rank

    61.23%
    DAWN enterprise value is higher than 61.23% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.98
    DAWN EV/EBITDA is -2.98

    EV/EBITDA Sector rank

    30.62%
    DAWN EV/EBITDA is higher than 30.62% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.66
    DAWN annual current ratio is 7.66

    Quick ratio

    7.61
    DAWN annual quick ratio is 7.61

    Leverage

    Debt to equity

    0.01
    DAWN annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    DAWN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    DAWN piotroski f-score is 3

    Altman Z-Score

    4.47
    DAWN altman z-score is 4.47

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 Needham
    Buy
    Aug 6, 25 HC Wainwright & Co.
    Buy
    May 7, 25 Needham
    Buy
    Apr 3, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 Goldman Sachs
    Buy
    Mar 5, 25 JP Morgan
    Overweight
    Feb 26, 25 Wedbush
    Outperform
    Feb 26, 25 Needham
    Buy
    Feb 26, 25 HC Wainwright & Co.
    Buy
    Feb 10, 25 Goldman Sachs
    Buy

    Institutional Ownership

    Screeners with DAWN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Day One Biopharmaceuticals, Inc.?
    • Does Day One Biopharmaceuticals, Inc. pay dividends?
    • What sector is Day One Biopharmaceuticals, Inc. in?
    • What industry is Day One Biopharmaceuticals, Inc. in?
    • What country is Day One Biopharmaceuticals, Inc. based in?
    • When did Day One Biopharmaceuticals, Inc. go public?
    • Is Day One Biopharmaceuticals, Inc. in the S&P 500?
    • Is Day One Biopharmaceuticals, Inc. in the NASDAQ 100?
    • Is Day One Biopharmaceuticals, Inc. in the Dow Jones?
    • When was Day One Biopharmaceuticals, Inc.'s last earnings report?
    • When does Day One Biopharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Day One Biopharmaceuticals, Inc.?

    The ticker symbol for Day One Biopharmaceuticals, Inc. is NASDAQ:DAWN

    Does Day One Biopharmaceuticals, Inc. pay dividends?

    No, Day One Biopharmaceuticals, Inc. does not pay dividends

    What sector is Day One Biopharmaceuticals, Inc. in?

    Day One Biopharmaceuticals, Inc. is in the Healthcare sector

    What industry is Day One Biopharmaceuticals, Inc. in?

    Day One Biopharmaceuticals, Inc. is in the Biotechnology industry

    What country is Day One Biopharmaceuticals, Inc. based in?

    Day One Biopharmaceuticals, Inc. is headquartered in United States

    When did Day One Biopharmaceuticals, Inc. go public?

    Day One Biopharmaceuticals, Inc.'s initial public offering (IPO) was on May 27, 2021

    Is Day One Biopharmaceuticals, Inc. in the S&P 500?

    No, Day One Biopharmaceuticals, Inc. is not included in the S&P 500 index

    Is Day One Biopharmaceuticals, Inc. in the NASDAQ 100?

    No, Day One Biopharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Day One Biopharmaceuticals, Inc. in the Dow Jones?

    No, Day One Biopharmaceuticals, Inc. is not included in the Dow Jones index

    When was Day One Biopharmaceuticals, Inc.'s last earnings report?

    Day One Biopharmaceuticals, Inc.'s most recent earnings report was on August 5, 2025

    When does Day One Biopharmaceuticals, Inc. report earnings?

    The next expected earnings date for Day One Biopharmaceuticals, Inc. is October 29, 2025
    On this page